$ Value
$107K
Shares
11,313
Price
$9
Filed
Mar 5
Insider
Name
Draghia-Akli Ruxandra
Title
EVP, Research & Development
CIK
0002041719
Roles
Transaction Details
Transaction Date
2026-03-03
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
23,563
Footnotes
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. | One-third (1/3) of the RSUs subject to this grant under Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date. | One quarter of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. | One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.
Filing Info
Draghia-Akli Ruxandra's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | NVAX | M | $0 |
| 2026-03-03 | NVAX | F | $107K |
| 2026-03-03 | NVAX | D | $0 |
| 2026-03-02 | NVAX | A | $0 |
| 2026-03-02 | NVAX | A | $0 |
| 2025-11-11 | NVAX | M | $0 |
| 2025-11-11 | NVAX | F | $45K |
| 2025-11-11 | NVAX | D | $0 |
Other Insiders at NVAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Casey Mark J
EVP, Chief Legal Officer
|
— | — | 2026-03-03 |
|
Kelly James Patrick
EVP, CFO and Treasurer
|
— | — | 2026-03-07 |
|
Jacobs John C
President and CEO
|
— | — | 2026-03-03 |
| Shiver John W. | — | — | 2026-03-10 |
|
O'Hara Elaine
EVP, Chief Strategy Officer
|
— | — | 2026-03-03 |
|
Draghia-Akli Ruxandra
EVP, Research & Development
|
— | — | 2026-03-03 |
|
Walker Robert Edward
EVP, R&D
|
— | — | 2026-04-14 |